Stem Cell Network
13 meetings with public office holders, Sep 15, 2025 to Jul 22, 2026.
20 meetings on record since 2023, their first on record.
Meetings over time
- Sep 2025: 1 meeting, with Nipun Vats
- Oct 2025: 0 meetings
- Nov 2025: 0 meetings
- Dec 2025: 0 meetings
- Jan 2026: 0 meetings
- Feb 2026: 0 meetings
- Mar 2026: 3 meetings, with David McFarlane, Karim Bardeesy, Maggie Chi
- Apr 2026: 2 meetings, with Tony Baldinelli, Celia Lourenco
- May 2026: 2 meetings, with Jagsharan Singh Mahal, Justine Frame
- Jun 2026: 1 meeting, with Justine Frame
- Jul 2026: 4 meetings, with Mackenzy Metcalfe, Manuela Tomic, Ritu Banerjee, Alexa Kalsatos
Sep 2025peak 4 in a monthJul 2026
Hover or focus a month to see who was met.
What they lobby about
- Science and Technology13
- Industry7
- Budget4
- Defence4
- Economic Development4
- Employment and Training4
- Research and Development4
- Health3
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Conservative2 met · 2 meetings
Liberal2 met · 2 meetings
Not in Arena's member list9 met · 9 meetings
- Alexa Kalsatos
- Celia Lourenco
- David McFarlane
- Justine Frame
- Justine Frame
- Mackenzy Metcalfe
- Manuela Tomic
- Nipun Vats
- Ritu Banerjee
House of Commons (5) · Innovation, Science and Economic Development Canada (ISED) (4) · Health Canada (HC) (2) · National Defence (DND) (1) · Finance Canada (FIN) (1)
In their own words
- Communicating with federal officials regarding the Strategic Science Fund and its role in supporting Canada’s research and innovation ecosystem, to ensure sustained support for stem cell and regenerative medicine research. Engagement will focus on enhancing stable funding to advance scientific excellence, collaboration, and sector growth.
- Continued support for life sciences funding and the emerging area of stem cell and regenerative medicine research. Lobbying is about building awareness about the field and the strength of talent that works within the field.
- Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.